Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
JUBILANT PHARMOVA TEVA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
JUBILANT PHARMOVA Mar-23 |
TEVA PHARMA Dec-13 |
JUBILANT PHARMOVA / TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 496 | 3,480 | - | |
Low | Rs | 269 | 3,023 | - | |
Sales per share (Unadj.) | Rs | 394.4 | 1,997.4 | - | |
Earnings per share (Unadj.) | Rs | -4.1 | 124.8 | - | |
Cash flow per share (Unadj.) | Rs | 30.7 | 286.2 | - | |
Dividends per share (Unadj.) | Rs | 5.00 | 109.23 | - | |
Avg Dividend yield | % | 1.3 | 3.4 | 38.9% | |
Book value per share (Unadj.) | Rs | 338.6 | 2,218.7 | - | |
Shares outstanding (eoy) | m | 159.28 | 848.00 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.0 | 1.6 | 59.5% | |
Avg P/E ratio | x | -93.8 | 26.1 | -360.0% | |
P/CF ratio (eoy) | x | 12.4 | 11.4 | 109.5% | |
Price / Book Value ratio | x | 1.1 | 1.5 | 77.0% | |
Dividend payout | % | -122.7 | 87.5 | -140.2% | |
Avg Mkt Cap | Rs m | 60,873 | 2,757,543 | 2.2% | |
No. of employees | `000 | NA | 44.9 | 0.0% | |
Total wages/salary | Rs m | 21,660 | 0 | - | |
Avg. sales/employee | Rs Th | 0 | 37,685.6 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 2,354.2 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 62,817 | 1,693,781 | 3.7% | |
Other income | Rs m | 383 | 0 | - | |
Total revenues | Rs m | 63,201 | 1,693,781 | 3.7% | |
Gross profit | Rs m | 7,317 | 463,843 | 1.6% | |
Depreciation | Rs m | 5,540 | 136,910 | 4.0% | |
Interest | Rs m | 1,882 | 33,269 | 5.7% | |
Profit before tax | Rs m | 278 | 293,664 | 0.1% | |
Minority Interest | Rs m | 0 | 1,334 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | -192,775 | -0.0% | |
Tax | Rs m | 927 | -3,585 | -25.8% | |
Profit after tax | Rs m | -649 | 105,809 | -0.6% | |
Gross profit margin | % | 11.6 | 27.4 | 42.5% | |
Effective tax rate | % | 333.5 | -1.2 | -27,319.6% | |
Net profit margin | % | -1.0 | 6.2 | -16.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 37,624 | 1,143,974 | 3.3% | |
Current liabilities | Rs m | 17,724 | 997,642 | 1.8% | |
Net working cap to sales | % | 31.7 | 8.6 | 366.7% | |
Current ratio | x | 2.1 | 1.1 | 185.1% | |
Inventory Days | Days | 25 | 91 | 27.0% | |
Debtors Days | Days | 56 | 96 | 58.2% | |
Net fixed assets | Rs m | 71,668 | 553,226 | 13.0% | |
Share capital | Rs m | 159 | 4,169 | 3.8% | |
Net worth | Rs m | 53,931 | 1,881,470 | 2.9% | |
Long term debt | Rs m | 31,104 | 866,068 | 3.6% | |
Total assets | Rs m | 109,292 | 3,870,833 | 2.8% | |
Interest coverage | x | 1.1 | 9.8 | 11.7% | |
Debt to equity ratio | x | 0.6 | 0.5 | 125.3% | |
Sales to assets ratio | x | 0.6 | 0.4 | 131.4% | |
Return on assets | % | 1.1 | 3.6 | 31.4% | |
Return on equity | % | -1.2 | 5.6 | -21.4% | |
Return on capital | % | 2.5 | 4.9 | 51.5% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 6,607 | 269,901 | 2.4% | |
From Investments | Rs m | -5,444 | -95,637 | 5.7% | |
From Financial Activity | Rs m | -1,567 | -323,765 | 0.5% | |
Net Cashflow | Rs m | 301 | -149,500 | -0.2% |
Compare JUBILANT PHARMOVA With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US)
Compare JUBILANT PHARMOVA With: GLENMARK LIFE SCIENCES BAL PHARMA AARTI DRUGS GODAVARI DRU MANKIND PHARMA
Asian markets traded higher on Tuesday following overnight gain on Wall Street.